Abstract
Purpose
Implant placement in patients with cancer receiving high-dose antiresorptive medication (HDAR) is considered contraindicated. This prospective, feasibility study tested the hypothesis that dental implants can be placed in such patients by applying a staged implant placement protocol with submerged healing.
Methods
Three groups of patients on HDAR were included as follows: group 1: patients who underwent tooth extraction, without the development of medication-related osteonecrosis of the jaws (MRONJ); group 2: patients with surgically treated MRONJ who had demonstrated clinical healing for at least 3 months; group 3: patients with established MRONJ who was planned for surgical resection and simultaneous implant placement.
Results
A total of 49 implants were placed in 27 patients (group 1: 12, group 2: 7 and group 3: 8). HDAR included bisphosphonates and denosumab. The mean HDAR time was 25 months (SD: ± 18.4, range 3–68 months). An abutment operation was performed 4 months following the implant placement (SD: ± 1.9, range 3–14 months). All patients healed uneventfully.
Conclusions
This study demonstrated that it is feasible to insert dental implants and perform an abutment surgery in patients with cancer on HDAR, without the development of MRONJ.
Trial registration.
ClinicalTrials.gov Identifier: NCT04741906.
Similar content being viewed by others
Availability of data and material
Not applicable.
Code availability
Not applicable.
References
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534. https://doi.org/10.1016/j.joms.2004.02.004
Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2(1):7–14. https://doi.org/10.1200/jop.2006.2.1.7
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 35(3):119–130. https://doi.org/10.1111/j.1747-4477.2009.00213.x
Schiodt M, Reibel J, Oturai P, Kofod T (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):204–213. https://doi.org/10.1016/j.oooo.2013.10.010
Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177–187. https://doi.org/10.1016/j.ctrv.2018.06.007
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23. https://doi.org/10.1002/jbmr.2405
Nicolatou-Galitis O, Schiødt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L, Niepel D, Van den Wyngaert T (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127(2):117–135. https://doi.org/10.1016/j.oooo.2018.09.008
Otto S, Troltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? J Craniomaxillofac Surg 43(6):847–854. https://doi.org/10.1016/j.jcms.2015.03.039
Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):e429-435. https://doi.org/10.1016/j.oooo.2012.08.442
Yazdi PM, Schiodt M (2015) Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort. Oral Surg Oral Med Oral Pathol Oral Radiol 119(4):416–422. https://doi.org/10.1016/j.oooo.2014.12.024
Werner S, Andersen M, Jensen S, Schiodt M (2020) Apical surgery in cancer patients receiving high-dose antiresorptive medication—a retrospective clinical study with a mean follow-up of 13 months. Oral Maxillofac Surg. https://doi.org/10.1007/s10006-020-00909-9
Gotfredsen K, Wiskott A (2012) Consensus report - reconstructions on implants. The Third EAO Consensus Conference 2012. Clin Oral Implants Res 23 Suppl 6:238–241. doi:https://doi.org/10.1111/j.1600-0501.2012.02549.x
Jung RE, Zembic A, Pjetursson BE, Zwahlen M, Thoma DS (2012) Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res 23(Suppl 6):2–21. https://doi.org/10.1111/j.1600-0501.2012.02547.x
Buser D, Janner SF, Wittneben JG, Brägger U, Ramseier CA, Salvi GE (2012) 10-year survival and success rates of 511 titanium implants with a sandblasted and acid-etched surface: a retrospective study in 303 partially edentulous patients. Clin Implant Dent Relat Res 14(6):839–851. https://doi.org/10.1111/j.1708-8208.2012.00456.x
Hjalmarsson L, Gheisarifar M, Jemt T (2016) A systematic review of survival of single implants as presented in longitudinal studies with a follow-up of at least 10 years. Eur J Oral Implantol 9(Suppl 1):S155-162
Walter C, Al-Nawas B, Wolff T, Schiegnitz E, Grotz KA (2016) Dental implants in patients treated with antiresorptive medication - a systematic literature review. Int J Implant Dent 2(1):9. https://doi.org/10.1186/s40729-016-0041-7
Schliephake H, Sicilia A, Nawas BA, Donos N, Gruber R, Jepsen S, Milinkovic I, Mombelli A, Navarro JM, Quirynen M, Rocchietta I, Schiodt M, Schou S, Stahli A, Stavropoulos A (2018) Drugs and diseases: summary and consensus statements of group 1. The 5(th) EAO Consensus Conference 2018. Clin Oral Implants Res 29 Suppl 18:93–99. doi:https://doi.org/10.1111/clr.13270
Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schiødt M, Klinge B (2018) The effect of antiresorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 1):54–92. https://doi.org/10.1111/clr.13282
Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W (1937) Wutzl A (2014) Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 72(10):e1931-1938. https://doi.org/10.1016/j.joms.2014.04.037
Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM (2014) Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates–a presentation of six consecutive cases. Clin Implant Dent Relat Res 16(5):751–761. https://doi.org/10.1111/cid.12048
Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI (2014) Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res 25(5):632–640. https://doi.org/10.1111/clr.12088
Jacobsen C, Metzler P, Rossle M, Obwegeser J, Zemann W, Gratz KW (2013) Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig 17(1):167–175. https://doi.org/10.1007/s00784-012-0708-2
Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N (2010) Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg 68(4):790–796. https://doi.org/10.1016/j.joms.2009.09.017
Heitz-Mayfield LJ, Aaboe M, Araujo M, Carrion JB, Cavalcanti R, Cionca N, Cochran D, Darby I, Funakoshi E, Gierthmuehlen PC, Hashim D, Jahangiri L, Kwon Y, Lambert F, Layton DM, Lorenzana ER, McKenna G, Mombelli A, Muller F, Roccuzzo M, Salvi GE, Schimmel M, Srinivasan M, Tomasi C, Yeo A (2018) Group 4 ITI Consensus Report: Risks and biologic complications associated with implant dentistry. Clin Oral Implants Res 29(Suppl 16):351–358. https://doi.org/10.1111/clr.13307
Schimmel M, Srinivasan M, McKenna G, Muller F (2018) Effect of advanced age and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 16):311–330. https://doi.org/10.1111/clr.13288
Chappuis V, Avila-Ortiz G, Araújo MG, Monje A (2018) Medication-related dental implant failure: systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 16):55–68. https://doi.org/10.1111/clr.13137
Jung RE, Al-Nawas B, Araujo M, Avila-Ortiz G, Barter S, Brodala N, Chappuis V, Chen B, De Souza A, Almeida RF, Fickl S, Finelle G, Ganeles J, Gholami H, Hammerle C, Jensen S, Jokstad A, Katsuyama H, Kleinheinz J, Kunavisarut C, Mardas N, Monje A, Papaspyridakos P, Payer M, Schiegnitz E, Smeets R, Stefanini M, Ten Bruggenkate C, Vazouras K, Weber HP, Weingart D, Windisch P (2018) Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes. Clin Oral Implants Res 29(Suppl 16):69–77. https://doi.org/10.1111/clr.13342
Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575. https://doi.org/10.1016/j.joms.2005.07.010
Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A (2007) Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 78(9):1664–1669. https://doi.org/10.1902/jop.2007.060514
Grant BT, Amenedo C, Freeman K, Kraut RA (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 66(2):223–230. https://doi.org/10.1016/j.joms.2007.09.019
Ata-Ali J, Ata-Ali F, Penarrocha-Oltra D, Galindo-Moreno P (2016) What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clin Oral Implants Res 27(2):e38-46. https://doi.org/10.1111/clr.12526
Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P (2016) Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis? J Craniofac Surg 27(3):697–701. https://doi.org/10.1097/scs.0000000000002564
Escobedo MF, Cobo JL, Junquera S, Milla J, Olay S, Junquera LM (2020) Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. J Stomatol Oral Maxillofac Surg 121 (1):40–48. doi:https://doi.org/10.1016/j.jormas.2019.04.012
van Kampen FM, van der Bilt A, Cune MS, Fontijn-Tekamp FA, Bosman F (2004) Masticatory function with implant-supported overdentures. J Dent Res 83(9):708–711. https://doi.org/10.1177/154405910408300910
Fueki K, Kimoto K, Ogawa T, Garrett NR (2007) Effect of implant-supported or retained dentures on masticatory performance: a systematic review. J Prosthet Dent 98(6):470–477. https://doi.org/10.1016/s0022-3913(07)60147-4
DeBaz C, Hahn J, Lang L, Palomo L (2015) Dental implant supported restorations improve quality of life in osteoporotic women. Int J Dent 2015:451923. https://doi.org/10.1155/2015/451923
Müller F, Schädler M, Wahlmann U, Newton JP (2004) The use of implant-supported prostheses in the functional and psychosocial rehabilitation of tumor patients. Int J Prosthodont 17(5):512–517
Amgen Europe (2015) Xgeva (denosumab) summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002173/WC500110381.pdf. October 20, 2021
Kimmel DB (2007) Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 86(11):1022–1033. https://doi.org/10.1177/154405910708601102
Wongchuensoontorn C, Liebehenschel N, Wagner K, Fakler O, Gutwald R, Schmelzeisen R, Sauerbier S (2009) Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. J Oral Maxillofac Surg 67(6):1311–1316. https://doi.org/10.1016/j.joms.2008.12.030
Ottesen C, Schiodt M, Jensen SS, Kofod T, Gotfredsen K (2021) Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation. Oral Surg Oral Med Oral Pathol Oral Radiol. https://doi.org/10.1016/j.oooo.2021.06.003
Acknowledgements
We thank Kasper Rasmus Kuniss Kriegbaum and Even Nisja for their surgical assistance. We also thank Ditte Mogensen for the proofreading and statistical analyses.
Funding
This work was supported by the committee KOF (Account for Dental Research) under the Danish Dental Association (grant no. 036, 2017); Amgen Limited, Cambridge, United Kingdom (grant no. 20167865, 2016); Institute Straumann AG, provided implants and abutments free of charge. Neither was involved in the study design, collection, analysis or interpretation of data, report writing or the decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
Sanne Werner Moeller Andersen: conceptualization, methodology, validation, formal analysis, investigation, data curation, writing original draft, writing review and editing, visualisation, supervision, project administration, founding acquisition
Morten Schiodt: principal investigator (PI) for the project, conceptualization, methodology, validation, formal analysis, investigation, resources, data curation, writing review and editing, visualisation, supervision, project administration, founding acquisition
Thomas Kofod: validation, investigation, resources, writing review and editing, supervision
Camilla Ottesen: validation, investigation, data curation, writing review and editing, visualisation
Klaus Godtfredsen: validation, investigation, resources, data curation, writing review and editing
Simon Storgaard Jensen: validation, writing review and editing, supervision
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the appropriate ethics committee H-17025531 October 10, 2017, and data protection agency No. 2012–41-0045 January 11, 2012.
Consent to participate
All patients signed an informed consent.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Morten Schiodt Passed away before the submission.
Rights and permissions
About this article
Cite this article
Andersen, S.W.M., Ottesen, C., Gotfredsen, K. et al. Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study. Oral Maxillofac Surg 27, 89–100 (2023). https://doi.org/10.1007/s10006-022-01042-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-022-01042-5